A derivative of a trendy if not overused moniker, used by many other industries to convey a new start, a new future, and substantial change from the past. Is biopharma manufacturing really at such a juncture? The committee members organizing ISPE’s 4th Annual Biopharmaceutical Manufacturing Conference think so! We’ve lined up biopharma industry thought leaders, key regulators, and innovation practitioners who are forging the future of biopharmaceutical production.
Need more evidence? There are 308 active or planned gene therapy clinical trials listed at ClinicalTrials.gov. How about 123 Antibody Drug Conjugate studies! These new modalities require a different manufacturing approach; creating challenges that require engineers, scientists, and operations professionals to learn new approaches and adapt old ones.
There is a lot of change on the horizon for the biopharmaceutical industry and staying at the forefront is of utmost importance. Please join me in Boston, 18 – 20 June, where thought leaders will inspire, practitioners will instruct, and you will be immersed in BioPharma 4.0. Boston is a global hub for biotechnology innovation and production. Early registration has demonstrated global interest, and the high density of local firms will provide invaluable technical and business networking opportunities.
Your journey to the future begins in Boston this June.
The UK Entered a New Relationship with the European Union on 1 Jan 2021 The United Kingdom (UK) (England, Northern Ireland, Scotland and Whales) is no longer part of the European Union (EU) Customs Union. Simply put, it means movement of goods between the UK and the EU are now to be an import and...
Featured in this edition of the Pharmaceutical Engineering Online Reading Roundup are the most read online articles during March 2021. Learn more about understanding cleanliness classifications, steam sterilization, and more from what visitors to the PE Online site were reading last month.
Featured in this edition of iSpeak Reading Roundup, are the top blog posts from March 2021. Discover key insights for cleaning validation practices, risk-based approaches to quality, and more for what the pharmaceutical industry was reading last month.